chinese
隐藏导航
x
Search
logo
News Center
NEWS CENTER
Homepage
/
Newsroom
/
Medomics Medical has awarded the EU CE certificate of the SARS-CoV-2 and Influenza A/B Antigen Combo rapid Test Kit (LFIA)

Medomics Medical has awarded the EU CE certificate of the SARS-CoV-2 and Influenza A/B Antigen Combo rapid Test Kit (LFIA)

  • Categories:Newsroom
  • Author:
  • Origin:
  • Time of issue:2022-07-19
  • Views:0

(Summary description)      On May 24th, Medomics Medical independently developed SARS-CoV-2 &Influenza A/B Antigen Combo Rapid Test Kit(LFIA) that can be used for this self test rapid combo  has obtained the CE self-test certificate issued by PCBC (1434), which means that Medomics Medical's triple inspection and self-test products have fully complied with the IVDD directive and the latest EU MDCG2021-21 Regulatory requirements, it can be sold in the EU and countries that recognize the EU CE self-test certificate. Medomics is the third IVD company to obtain the CE certificate of triple inspection and self-test, and the first company in the world to pass the audit and certification of this self test rapid combo inspection and self-test certificate by the well-known announcement agency UL.

 


Medomics Medical has awarded the EU CE certificate of the SARS-CoV-2 and Influenza A/B Antigen Combo rapid Test Kit (LFIA)

(Summary description)      On May 24th, Medomics Medical independently developed SARS-CoV-2 &Influenza A/B Antigen Combo Rapid Test Kit(LFIA) that can be used for this self test rapid combo  has obtained the CE self-test certificate issued by PCBC (1434), which means that Medomics Medical's triple inspection and self-test products have fully complied with the IVDD directive and the latest EU MDCG2021-21 Regulatory requirements, it can be sold in the EU and countries that recognize the EU CE self-test certificate. Medomics is the third IVD company to obtain the CE certificate of triple inspection and self-test, and the first company in the world to pass the audit and certification of this self test rapid combo inspection and self-test certificate by the well-known announcement agency UL.

 


  • Categories:Newsroom
  • Author:
  • Origin:
  • Time of issue:2022-07-19
  • Views:0
Information

      On May 24th, Medomics Medical independently developed SARS-CoV-2 &Influenza A/B Antigen Combo Rapid Test Kit(LFIA) that can be used for this self test rapid combo  has obtained the CE self-test certificate issued by PCBC (1434), which means that Medomics Medical's triple inspection and self-test products have fully complied with the IVDD directive and the latest EU MDCG2021-21 Regulatory requirements, it can be sold in the EU and countries that recognize the EU CE self-test certificate. Medomics is the third IVD company to obtain the CE certificate of triple inspection and self-test, and the first company in the world to pass the audit and certification of this self test rapid combo inspection and self-test certificate by the well-known announcement agency UL.

 

Scan the QR code to read on your phone

Previous: Medomics Medical contributes to global epidemic prevention and control, and has been approved two more certifications
Next: Nearly 10 million test kits were released quickly, Medomics Medical helped Hong Kong to fight the epidemic
Previous: Medomics Medical contributes to global epidemic prevention and control, and has been approved two more certifications
Next: Nearly 10 million test kits were released quickly, Medomics Medical helped Hong Kong to fight the epidemic
APALT

FOLLOW MEDOMICS

APALT

Product Center

Infectious Disease

Contact Us

Phone： (+86) 025 - 58601060

E-mail: overseas@medomics-dx.com
Address：3 / F, Building D, Phase II, Zhongdan Ecological Life Science Industrial Park, 3-1 Xinjinhu Road, Jiangbei New District, Nanjing

 

Jiangsu Medomics Medical Technology Co,Ltd    Powered By www.300.cn